Brief: Springworks Therapeutics Announces PDUFA Date Extension For Nirogacestat NDA
June 5 (Reuters) - SpringWorks Therapeutics Inc
SWTX.O :
* SPRINGWORKS THERAPEUTICS ANNOUNCES PDUFA DATE EXTENSION
FOR
NIROGACESTAT NDA
* SPRINGWORKS THERAPEUTICS INC - PREVIOUSLY DISCLOSED AUGUST
27,
2023 PDUFA DATE HAS BEEN EXTENDED BY STANDARD EXTENSION PERIOD
OF THREE MONTHS
Source text for Eikon: ID:nGNX2MWZgr
Further company coverage: SWTX.O
Recent news on SpringWorks Therapeutics
See all newsBrief: Merck KGaA Completes Acquisition Of Springworks Therapeutics
Brief: Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3
Brief: EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer’S Treatment
Brief: SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
Brief: SpringWorks Therapeutics Receives Positive CHMP Opinion For Mirdametinib For The Treatment Of Adult And Pediatric Patients With NF1-PN